Acrodermatitis chronica atrophicans: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (15 intermediate revisions by 6 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
'''For patient information, click [[Acrodermatitis chronica atrophicans (patient information)|here]]''' | |||
{{ACA}} | {{ACA}} | ||
{{CMG}}; {{AE}} {{RT}} | {{CMG}}; {{AE}} {{Anahita}} {{RT}} | ||
{{SK}} Pick-Herxheimer disease; ACA | {{SK}} Pick-Herxheimer disease; Herxheimer disease; primary diffuse atrophy; ACA | ||
==[[Acrodermatitis chronica atrophicans overview|Overview]]== | ==[[Acrodermatitis chronica atrophicans overview|Overview]]== | ||
==[[Acrodermatitis chronica atrophicans historical perspective|Historical Perspective]]== | ==[[Acrodermatitis chronica atrophicans historical perspective|Historical Perspective]]== | ||
==[[Acrodermatitis chronica atrophicans pathophysiology|Pathophysiology]]== | ==[[Acrodermatitis chronica atrophicans pathophysiology|Pathophysiology]]== | ||
==[[Acrodermatitis chronica atrophicans causes|Causes]]== | ==[[Acrodermatitis chronica atrophicans causes|Causes]]== | ||
==[[Acrodermatitis chronica atrophicans differential diagnosis|Differentiating Acrodermatitis chronica atrophicans from other | ==[[Acrodermatitis chronica atrophicans differential diagnosis|Differentiating Acrodermatitis chronica atrophicans from other Diseases]]== | ||
==[[Acrodermatitis chronica atrophicans epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Acrodermatitis chronica atrophicans epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Acrodermatitis chronica atrophicans risk factors|Risk Factors]]== | ==[[Acrodermatitis chronica atrophicans risk factors|Risk Factors]]== | ||
==[[Acrodermatitis_chronica_atrophicans_natural_history,_complications_and_prognosis|Natural History, Complications and Prognosis]]== | |||
==[[Acrodermatitis_chronica_atrophicans_natural_history,_complications_and_prognosis|Natural History, Complications | |||
==Diagnosis== | ==Diagnosis== | ||
[[Acrodermatitis chronica atrophicans history and symptoms|History and Symptoms]] | [[Acrodermatitis chronica atrophicans physical examination|Physical Examination]] | [[Acrodermatitis chronica atrophicans laboratory findings|Laboratory Findings]] | [[Acrodermatitis chronica atrophicans other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | |||
[[Acrodermatitis chronica atrophicans medical therapy|Medical Therapy]] | [[Acrodermatitis chronica atrophicans primary prevention|Primary Prevention]] | [[Acrodermatitis chronica atrophicans secondary prevention|Secondary Prevention]] | [[Acrodermatitis chronica atrophicans cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acrodermatitis chronica atrophicans future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Acrodermatitis chronica atrophicans case study one|Case #1]] | |||
=Related Chapters= | ==Related Chapters== | ||
*[[Lyme Disease]] | *[[Lyme Disease]] | ||
*[[erythema migrans|Erythema Migrans]] | *[[erythema migrans|Erythema Migrans]] | ||
| Line 40: | Line 34: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Insect-borne diseases]] | [[Category:Insect-borne diseases]] | ||
[[Category:Lyme disease]] | [[Category:Lyme disease]] | ||
[[Category:Zoonoses]] | [[Category:Zoonoses]] | ||
[[Category:Spirochaetes]] | [[Category:Spirochaetes]] | ||
Latest revision as of 07:54, 4 August 2022
For patient information, click here
|
Acrodermatitis chronica atrophicans Microchapters |
|
Differentiating Acrodermatitis chronica atrophicans from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acrodermatitis chronica atrophicans On the Web |
|
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans |
|
Risk calculators and risk factors for Acrodermatitis chronica atrophicans |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2] Raviteja Guddeti, M.B.B.S. [3]
Synonyms and keywords: Pick-Herxheimer disease; Herxheimer disease; primary diffuse atrophy; ACA
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Acrodermatitis chronica atrophicans from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies